Table of Contents
Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1.Exosome Diagnostic and Therapeutic Market, by Region, 2020-2030 (USD Million)
1.2.2.Exosome Diagnostic and Therapeutic Market, by Application, 2020-2030 (USD Million)
1.2.3.Exosome Diagnostic and Therapeutic Market, by Product, 2020-2030 (USD Million)
1.2.4.Exosome Diagnostic and Therapeutic Market, by End User, 2020-2030 (USD Million)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Global Exosome Diagnostic and Therapeutic Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Global Exosome Diagnostic and Therapeutic Market Dynamics
3.1.Exosome Diagnostic and Therapeutic Market Impact Analysis (2020-2030)
3.1.1.Market Drivers
3.1.1.1.Increasing Prevalence of Chronic Disease
3.1.1.2.Surge In Demand for Molecular Diagnosis
3.1.2.Market Challenges
3.1.2.1.High Development Cost of Exosome Based Therapeutic Drugs
3.1.2.2.Stringent Government Regulations on Drug Approval
3.1.3.Market Opportunities
3.1.3.1.Integration Of Advance Exosome Technology in Drug Development
3.1.3.2.Increasing Development of Translational Precision Medicine
Chapter 4.Global Exosome Diagnostic and Therapeutic Market Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
4.3.1.Political
4.3.2.Economical
4.3.3.Social
4.3.4.Technological
4.3.5.Environmental
4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion
Chapter 5.Global Exosome Diagnostic and Therapeutic Market, by Application
5.1.Market Snapshot
5.2.Global Exosome Diagnostic and Therapeutic Market by Application, Performance - Potential Analysis
5.3.Global Exosome Diagnostic and Therapeutic Market Estimates & Forecasts by Application 2020-2030 (USD Million)
5.4.Exosome Diagnostic and Therapeutic Market, Sub Segment Analysis
5.4.1.Diagnostic
5.4.2.Therapeutic
Chapter 6.Global Exosome Diagnostic and Therapeutic Market, by Product
6.1.Market Snapshot
6.2.Global Exosome Diagnostic and Therapeutic Market by Product, Performance - Potential Analysis
6.3.Global Exosome Diagnostic and Therapeutic Market Estimates & Forecasts by Product 2020-2030 (USD Million)
6.4.Exosome Diagnostic and Therapeutic Market, Sub Segment Analysis
6.4.1.Instrument
6.4.2.Reagent
6.4.3.Software
Chapter 7.Global Exosome Diagnostic and Therapeutic Market, by End User
7.1.Market Snapshot
7.2.Global Exosome Diagnostic and Therapeutic Market by End User, Performance - Potential Analysis
7.3.Global Exosome Diagnostic and Therapeutic Market Estimates & Forecasts by End User 2020-2030 (USD Million)
7.4.Exosome Diagnostic and Therapeutic Market, Sub Segment Analysis
7.4.1.Cancer Institute
7.4.2.Hospital
7.4.3.Diagnostic Center
7.4.4.Others
Chapter 8.Global Exosome Diagnostic and Therapeutic Market, Regional Analysis
8.1.Top Leading Countries
8.2.Top Emerging Countries
8.3.Exosome Diagnostic and Therapeutic Market, Regional Market Snapshot
8.4.North America Exosome Diagnostic and Therapeutic Market
8.4.1.U.S. Exosome Diagnostic and Therapeutic Market
8.4.1.1.Application breakdown estimates & forecasts, 2020-2030
8.4.1.2.Product breakdown estimates & forecasts, 2020-2030
8.4.1.3.End User breakdown estimates & forecasts, 2020-2030
8.4.2.Canada Exosome Diagnostic and Therapeutic Market
8.5.Europe Exosome Diagnostic and Therapeutic Market Snapshot
8.5.1.U.K. Exosome Diagnostic and Therapeutic Market
8.5.2.Germany Exosome Diagnostic and Therapeutic Market
8.5.3.France Exosome Diagnostic and Therapeutic Market
8.5.4.Spain Exosome Diagnostic and Therapeutic Market
8.5.5.Italy Exosome Diagnostic and Therapeutic Market
8.5.6.Rest of Europe Exosome Diagnostic and Therapeutic Market
8.6.Asia-Pacific Exosome Diagnostic and Therapeutic Market Snapshot
8.6.1.China Exosome Diagnostic and Therapeutic Market
8.6.2.India Exosome Diagnostic and Therapeutic Market
8.6.3.Japan Exosome Diagnostic and Therapeutic Market
8.6.4.Australia Exosome Diagnostic and Therapeutic Market
8.6.5.South Korea Exosome Diagnostic and Therapeutic Market
8.6.6.Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market
8.7.Latin America Exosome Diagnostic and Therapeutic Market Snapshot
8.7.1.Brazil Exosome Diagnostic and Therapeutic Market
8.7.2.Mexico Exosome Diagnostic and Therapeutic Market
8.8.Middle East & Africa Exosome Diagnostic and Therapeutic Market
8.8.1.Saudi Arabia Exosome Diagnostic and Therapeutic Market
8.8.2.South Africa Exosome Diagnostic and Therapeutic Market
8.8.3.Rest of Middle East & Africa Exosome Diagnostic and Therapeutic Market
Chapter 9.Competitive Intelligence
9.1.Key Company SWOT Analysis
9.2.Top Market Strategies
9.3.Company Profiles
9.3.1.Malvern Instruments Limited
9.3.1.1.Key Information
9.3.1.2.Overview
9.3.1.3.Financial (Subject to Data Availability)
9.3.1.4.Product Summary
9.3.1.5.Recent Developments
9.3.2.System Biosciences Incorporated
9.3.3.Exiqon A/S
9.3.4.Capricor Therapeutics, Inc.
9.3.5.NanoSomix, Inc.
9.3.6.Thermo Fisher Scientific Incorporated
9.3.7.Sistemic Limited
9.3.8.Exosome Diagnostic, Inc.
9.3.9.NX Pharmagen, Inc.
9.3.10.Aethlon Medical, Inc
Chapter 10.Research Process
10.1.Research Process
10.1.1.Data Mining
10.1.2.Analysis
10.1.3.Market Estimation
10.1.4.Validation
10.1.5.Publishing
10.2.Research Attributes
10.3.Research Assumption